DDInter1845 DDInter834
A propylamine formed from the cyclization of the side chain of amphetamine. This monoamine oxidase inhibitor is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in panic and phobic disorders (From AMA Drug Evaluations Annual, 1994, p311). Tranylcypromine is a racemate comprising equal amounts of (1R,2S)- and (1S,2R)-2-phenylcyclopropan-1-amine with the chiral centers both located on the cylopropane ring. An irreversible monoamine oxidase inhibitor that is used as an antidepressant (INN tranylcypromine).
Glycopyrronium, also known as NVA237 or glycopyrrolate, is a racemic mixture of two enantiomers. They are both quaternary ammonium compounds and long acting muscarinic antagonists. It is one of the most commonly prescribed anticholinergic medications.[A233535,A233540] Early research into glycopyrronium use was for its indication as an adjunct therapy in the treatment of peptic ulcers.[A233570,L33090] Later research, taking advantage of the systemic distribution of muscarinic receptors through the body, found that glycopyrronium could also be used for reducing sweat gland, oral, airway, and gastric secretions; as well as reducing cardiac inhibitory reflexes; and reducing bronchoconstriction in COPD. Glycopyrronium is commonly prescribed as a first line treatment for a wide variety indications and is considered to have a wider therapeutic window than [tiotropium]. Glycopyrronium was originally granted FDA approval on 11 August 1961.
Tranylcypromine {u} (Compound) causes {v} (Side Effect) Vision blurred
Vision blurred {u} (Side Effect) is caused by {v} (Compound) Glycopyrronium
Tranylcypromine {u} (Compound) resembles {v} (Compound) Phenelzine
Phenelzine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Glycopyrronium
Tranylcypromine {u} (Compound) causes {v} (Side Effect) Vision blurred
Vision blurred {u} (Side Effect) is caused by {v} (Compound) Mepenzolate
Mepenzolate {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Glycopyrronium
Tranylcypromine {u} (Compound) causes {v} (Side Effect) Oedema
Oedema {u} (Side Effect) is caused by {v} (Compound) Oxybutynin
Oxybutynin {u} (Compound) resembles {v} (Compound) Glycopyrronium
Tranylcypromine {u} (Compound) causes {v} (Side Effect) Pallor
Pallor {u} (Side Effect) is caused by {v} (Compound) Nitroglycerin
Nitroglycerin {u} may cause a minor interaction that can limit clinical effects when taken with {v} Glycopyrronium
Tranylcypromine {u} (Compound) resembles {v} (Compound) Phentermine
Phentermine {u} may lead to a major life threatening interaction when taken with {v} Phenelzine
Phenelzine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Glycopyrronium
Tranylcypromine {u} (Compound) resembles {v} (Compound) Phenelzine
Phenelzine {u} (Compound) causes {v} (Side Effect) Hyperpyrexia
Hyperpyrexia {u} (Side Effect) is caused by {v} (Compound) Glycopyrronium
Tranylcypromine {u} (Compound) causes {v} (Side Effect) Pain
Pain {u} (Side Effect) is caused by {v} (Compound) Hydrochlorothiazide
Hydrochlorothiazide {u} may cause a minor interaction that can limit clinical effects when taken with {v} Glycopyrronium
Tranylcypromine {u} (Compound) resembles {v} (Compound) Dextroamphetamine
Dextroamphetamine {u} (Compound) resembles {v} (Compound) Phenelzine
Phenelzine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Glycopyrronium
Tranylcypromine {u} (Compound) causes {v} (Side Effect) Pallor
Pallor {u} (Side Effect) is caused by {v} (Compound) Morphine
Morphine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Glycopyrronium
Tranylcypromine (Compound) causes Vision blurred (Side Effect) and Vision blurred (Side Effect) is caused by Glycopyrronium (Compound)
Tranylcypromine (Compound) resembles Phenelzine (Compound) and Phenelzine may cause a minor interaction that can limit clinical effects when taken with Glycopyrronium
Tranylcypromine (Compound) causes Vision blurred (Side Effect) and Vision blurred (Side Effect) is caused by Mepenzolate (Compound) and Mepenzolate may cause a moderate interaction that could exacerbate diseases when taken with Glycopyrronium
Tranylcypromine (Compound) causes Oedema (Side Effect) and Oedema (Side Effect) is caused by Oxybutynin (Compound) and Oxybutynin (Compound) resembles Glycopyrronium (Compound)
Tranylcypromine (Compound) causes Pallor (Side Effect) and Pallor (Side Effect) is caused by Nitroglycerin (Compound) and Nitroglycerin may cause a minor interaction that can limit clinical effects when taken with Glycopyrronium
Tranylcypromine (Compound) resembles Phentermine (Compound) and Phentermine may lead to a major life threatening interaction when taken with Phenelzine and Phenelzine may cause a minor interaction that can limit clinical effects when taken with Glycopyrronium
Tranylcypromine (Compound) resembles Phenelzine (Compound) and Phenelzine (Compound) causes Hyperpyrexia (Side Effect) and Hyperpyrexia (Side Effect) is caused by Glycopyrronium (Compound)
Tranylcypromine (Compound) causes Pain (Side Effect) and Pain (Side Effect) is caused by Hydrochlorothiazide (Compound) and Hydrochlorothiazide may cause a minor interaction that can limit clinical effects when taken with Glycopyrronium
Tranylcypromine (Compound) resembles Dextroamphetamine (Compound) and Dextroamphetamine (Compound) resembles Phenelzine (Compound) and Phenelzine may cause a minor interaction that can limit clinical effects when taken with Glycopyrronium
Tranylcypromine (Compound) causes Pallor (Side Effect) and Pallor (Side Effect) is caused by Morphine (Compound) and Morphine may cause a moderate interaction that could exacerbate diseases when taken with Glycopyrronium